Tuesday, September 13, 2016

Two Different Treatments for Type One Diabetes in the Works


Dr. Kumud Verma M.D. treats patients at his family practice in North Delta, Canada.He is also involved in serving his community by providing Circumcisions of Newborn baby boys using the latest techniques. Further information can be acquired via his website: https://www.surreydeltacircumcision.com/   .Alongside the general services he provides for families, Dr. Kumud Verma maintains a special interest in diabetes and the management of diabetes through insulin treatments.

In early 2016, researchers from the ViaCyte biotechnology company commenced patient trials on a new therapy for type one diabetes. The treatment relies on embryonic stem cells, which are turned into the insulin-producing cells that type one patients lack. Special capsules protect these cells from the patient's own immune system, which would usually attack them. If all goes well, these capsule-bound cells will create enough insulin to reach normal levels.

A slightly different treatment is being tested at Guy's Hospital in London, England. Rather than creating the insulin-producing cells the body rejects, this technique uses peptides to “switch off” the body's attack on those cells, allowing them to produce insulin. The special proprietary peptide is called MultiPepT1De, and it has already produced what researchers describe as encouraging results.